The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria

Marcus Maurer(Humboldt-Universität zu Berlin), Thomas B. Casale(University of South Florida), Allen P. Kaplan(Medical University of South Carolina), Karin Rosén(Baylor College of Medicine), Ahmar Iqbal(Johns Hopkins University), Ming Yang(Fujian Medical University), Michael P. Holden, Benjamin Trzaskoma(MDS Associates (United States))
Journal of Allergy and Clinical Immunology
November 10, 2017
Cited by 89


Related Papers